Sustained Analgesic Effect of the Rho Kinase Inhibitor AS1892802 in Rat Models of Chronic Pain
To assess the pharmacological profile of AS1892802, a novel and selective Rho kinase (ROCK) inhibitor, we examined the effects of repeated dosing with AS1892802 on models of monoiodoacetate-induced arthritis and streptozotocin-induced neuropathy. Although single dosing of AS1892802 exerted a short-a...
Main Authors: | Eiji Yoshimi, Hiroko Yamamoto, Yasuhisa Furuichi, Yasuaki Shimizu, Nobuaki Takeshita |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319308898 |
Similar Items
-
Alleviating Effects of AS1892802, a Rho Kinase Inhibitor, on Osteoarthritic Disorders in Rodents
by: Nobuaki Takeshita, et al.
Published: (2011-01-01) -
Rho-kinase inhibitors in ophthalmology
by: Megha Gopalakrishna, et al.
Published: (2021-01-01) -
The Role of Rho Kinase Inhibitors in Corneal Diseases
by: Futterknecht S, et al.
Published: (2024-01-01) -
Investigational Rho Kinase Inhibitors for the Treatment of Glaucoma
by: Al-Humimat G, et al.
Published: (2021-02-01) -
Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy
by: Jun Wang, et al.
Published: (2023-10-01)